Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
2018/06/08Number of shares and voting rights of ADOCIA as of May, 31 2018
2018/05/07Number of shares and voting rights of ADOCIA as of April, 30 2018
22-26 June, 2018 American Diabetes Association (ADA), 78th scientific sessions, Orlando, USA - The world's largest, most prominent meeting on diabetes ! The Scientific Sessions offers researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care.